|
Volumn 893-894, Issue , 2012, Pages 92-100
|
Corrigendum to "Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine" [J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 893-894 (2012) 92-100] DOI: 10.1016/j.jchromb.2012.02.039.;Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine
|
Author keywords
Alkylating agent; Bendamustine; LC MS MS; Metabolites; Stability
|
Indexed keywords
ASSAYS;
BIOMOLECULES;
BODY FLUIDS;
CONVERGENCE OF NUMERICAL METHODS;
DISEASES;
ELECTROSPRAY IONIZATION;
HYDROLYSIS;
LIQUID CHROMATOGRAPHY;
MASS SPECTROMETRY;
METABOLITES;
PATIENT MONITORING;
PATIENT TREATMENT;
PHASE SEPARATION;
PLASMA (HUMAN);
SOLUTIONS;
ALKYLATING AGENTS;
BENDAMUSTINE;
CONCENTRATION LEVELS;
LC-MS/MS;
LOWER LIMIT OF QUANTIFICATIONS;
PHARMACOKINETIC PROFILES;
SENSITIVE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY;
SOLID-PHASE EXTRACTION;
NITROGEN PLASMA;
AMMONIUM FORMATE;
BENDAMUSTINE;
DIHYDROXYBENDAMUSTINE;
DRUG METABOLITE;
FORMIC ACID;
GAMMA HYDROXYBENDAMUSTINE;
METHANOL;
N DES METHYBENDAMUSTINE;
UNCLASSIFIED DRUG;
WATER;
ACCURACY;
ACIDIFICATION;
ARTICLE;
BLOOD SAMPLING;
CONTROLLED STUDY;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG URINE LEVEL;
ELECTROSPRAY;
HUMAN;
HUMAN TISSUE;
LIMIT OF QUANTITATION;
LIQUID CHROMATOGRAPHY;
MASS SPECTROMETER;
PRIORITY JOURNAL;
SOLID PHASE EXTRACTION;
TANDEM MASS SPECTROMETRY;
BRASSICACEAE;
|
EID: 84859443885
PISSN: 15700232
EISSN: 1873376X
Source Type: Journal
DOI: 10.1016/j.jchromb.2016.03.016 Document Type: Erratum |
Times cited : (34)
|
References (9)
|